MSB 4.69% $1.45 mesoblast limited

Editorial from Biotech Daily, page-56

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    It shows the level of confidence in this company to have large pharmas actually paying for the trials how often does that happen?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.